About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

About Market Research Forecast

U.S. Livestock Vaccines Market

U.S. Livestock Vaccines Market Insightful Analysis: Trends, Competitor Dynamics, and Opportunities 2025-2033

U.S. Livestock Vaccines Market by Type (Inactivated, Live Attenuated, Recombinant, Others), by Animal Type (Bovine, Swine/ Porcine, Poultry, Others), by Route of Administration (Oral, Parenteral, Others), by Distributional Channel (Veterinary Hospitals, Veterinary Clinics, Others), by Forecast 2026-2034

Jan 26 2026

Base Year: 2025

120 Pages

U.S. Livestock Vaccines Market Insightful Analysis: Trends, Competitor Dynamics, and Opportunities 2025-2033

Key Insights

The U.S. Livestock Vaccines Market size was valued at USD 2.36 USD Billion in 2023 and is projected to reach USD 3.55 USD Billion by 2032, exhibiting a CAGR of 6.0 % during the forecast period. Livestock vaccines are biologics whose function is to boost the immune system of animals such as cattle, sheep, pigs, and poultry among others against specific diseases. Examples are LAVs, IVs, Sub-Unit vaccines, and DNA vaccines. These include specificity high safety and efficacy in disease prevention. Possible areas of use include disease management, increase in working efficiency, and safety of food products. The current trends in the USA market indicate an upsurge in demand attributable to rising livestock infections, innovation of the vaccine, and a generally heightened concern for animal health and wellbeing. Other factors that fuel market growth include novel technologies like recombinant vaccines and multi-disease vaccines.

U.S. Livestock Vaccine Trends

Increasing adoption of preventive healthcare measures
Growing demand for high-quality vaccines
Development of new and innovative vaccines

U.S. Livestock Vaccines Market Market Size and Forecast (2024-2030) — U.S. Livestock Vaccines Market Company Market Share

Driving Forces: What's Propelling the U.S. Livestock Vaccines Market

Rising Livestock Disease Incidents & Zoonotic Concerns: The escalating frequency of livestock diseases, coupled with the persistent threat of zoonotic diseases (transmissible to humans) and emerging/re-emerging infections, significantly fuels the demand for effective livestock vaccines. These vaccines are critical for proactive prevention, rapid outbreak control, and safeguarding both animal and public health.
Robust Government Initiatives & Financial Support: Proactive government bodies like the U.S. Department of Agriculture (USDA) and state animal health departments are instrumental in bolstering animal health. Their comprehensive initiatives encompass rigorous disease surveillance, widespread vaccination campaigns, and crucial financial incentives and grants for livestock producers, thereby fostering widespread adoption of preventative health measures.
Innovations in Vaccine Technology & Efficacy: Significant strides in vaccine research and development, particularly with the advent of cutting-edge platforms such as recombinant DNA technology and mRNA vaccine platforms, are revolutionizing livestock immunization. These innovations are yielding a new generation of highly effective, precisely targeted, and often more adaptable vaccines, offering enhanced protection against a broader spectrum of diseases.
Growing Consumer Demand for Healthier Livestock Products: An increasing consumer awareness and demand for high-quality, safely produced meat, dairy, and egg products directly impacts the livestock industry. Producers are investing more in preventative health measures, including robust vaccination programs, to ensure the well-being of their animals, leading to healthier herds and flocks and ultimately, safer food supplies.
Expansion of the Livestock Sector & Increased Farm Productivity: The continuous growth in the U.S. livestock population across various species (cattle, swine, poultry, etc.) and the drive for enhanced farm productivity necessitate robust disease management strategies. Vaccines play a pivotal role in minimizing losses due to illness, ensuring consistent production cycles, and maximizing the economic viability of livestock operations.

Challenges and Restraints in the U.S. Livestock Vaccines Market

High cost of vaccines
Stringent regulatory approvals
Increasing competition from generic vaccines

Emerging Trends in U.S. Livestock Vaccines

Focus on thermostable vaccines
Combination vaccines to protect against multiple diseases
Development of vaccines for emerging diseases

Growth Catalysts in U.S. Livestock Vaccines Industry

Partnerships between vaccine manufacturers and livestock producers: These partnerships enable companies to develop and distribute vaccines that meet the specific needs of livestock producers, leading to increased efficiency and profitability.
Government funding for research and development: Federal and state agencies provide funding for research into new and improved vaccines, advancing the industry and safeguarding livestock populations.
Increasing adoption of online vaccine purchasing: Online platforms offer convenience and cost benefits to producers, simplifying the procurement process and making vaccines more readily available.

Additional Growth Factors:

Rising demand for livestock products: As the global population grows, the demand for animal-based food products is increasing, driving the need for healthy and vaccinated livestock populations.
Emergence of new and emerging diseases: The spread of diseases like African swine fever and avian influenza highlights the importance of preventive measures, including vaccination.
Government regulations and standards: Governments enforce regulations on animal health and welfare, ensuring the safety and efficacy of vaccines and promoting their widespread use.

Market Segmentation: U.S. Livestock Vaccines Analysis

By Type:

Inactivated
Live Attenuated
Recombinant
Others

By Animal Type:

Bovine
Swine/Porcine
Poultry
Others

By Route of Administration:

Oral
Parenteral
Others

By Distributional Channel:

Veterinary Hospitals
Veterinary Clinics
Others

Leading Players in the U.S. Livestock Vaccines Market

Boehringer Ingelheim International GmbH (Germany)
Virbac (France)
Merck Animal Health (Merck & Co., Inc.) (U.S.)
Zoetis Services LLC (U.S.)
Ceva (France)
Elanco (U.S.)
Neogen Corporation (U.S.)

Significant Developments in the U.S. Livestock Vaccines Sector

July 2023:

The College of Veterinary Medicine of Kansas State University announced the inauguration of a Center on Vaccine Evaluation and Alternatives for Antimicrobials (CVEAA). The center will support research and development of new and innovative livestock and animal vaccines.

January 2021:

Zoetis Services LLC launched Poulvac, Procerta HVT-IBD vaccine, to protect poultry from infectious bursal disease (IBD) viruses and broadened its product portfolio.

August 2020:

Merck Animal Health (Merck & Co., Inc.) gained rights to VECOXAN, including in the U.S., for calves and lambs to prevent them from coccidiosis.

Comprehensive Coverage U.S. Livestock Vaccines Market Report

Market Overview
Key market trends
Growth drivers and challenges
Market segmentation
Competitive landscape
Key company profiles
Industry case studies

DROCT

Drivers: Increasing incidence of livestock diseases
Restraints: High cost of vaccines
Opportunities: Increasing awareness about vaccination
Challenges: Stringent regulatory approvals
Threats: Competition from generic vaccines

Pricing Analysis

The price of livestock vaccines varies depending on the type of vaccine, the animal type it is intended for, and the route of administration. In general, inactivated vaccines are more expensive than live attenuated vaccines. Recombinant vaccines are typically the most expensive type of vaccine.

Import And Export Analysis

The U.S. is a major importer of livestock vaccines. The largest sources of imported vaccines are the European Union, Canada, and Mexico. The U.S. also exports livestock vaccines to other countries, such as Mexico, Canada, and Japan.

Segmentation

The market can be segmented based on the type of vaccine, animal species, route of administration, and distribution channel.

Patent/Trademark Analysis

There are a number of patents and trademarks associated with the livestock vaccines market. Some of the most important patents and trademarks include:

U.S. Patent No. 8,349,359: This patent covers a method for producing a recombinant vaccine for foot-and-mouth disease.
U.S. Patent No. 8,293,242: This patent covers a composition for preventing or treating respiratory diseases in poultry.
U.S. Trademark No. 2,826,207: This trademark is for the name "Poulvac".

U.S. Livestock Vaccines Market REPORT HIGHLIGHTS

Aspects	Details
Study Period	2020-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2020-2025
Growth Rate	CAGR of 6.0% from 2020-2034
Segmentation	By Type Inactivated Live Attenuated Recombinant Others By Animal Type Bovine Swine/ Porcine Poultry Others By Route of Administration Oral Parenteral Others By Distributional Channel Veterinary Hospitals Veterinary Clinics Others By Geography

1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
- 2.1. Introduction
3. Market Dynamics
- 3.1. Introduction
- - 3.2. Market Drivers
  - - 3.2.1. Growing Awareness Regarding Contraceptive Drugs Leads to Product Demand
- - 3.3. Market Restrains
  - - 3.3.1. Growing Concerns Over Vaccine Failure Could Hinder the Market Growth
- - 3.4. Market Trends
  - - 3.4.1. Increasing Number of Hospitals and ASCs Identified as Significant Market Trend
4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
5. U.S. Livestock Vaccines Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Type
  - 5.1.1. Inactivated
  - 5.1.2. Live Attenuated
  - 5.1.3. Recombinant
  - 5.1.4. Others
- 5.2. Market Analysis, Insights and Forecast - by Animal Type
  - 5.2.1. Bovine
  - 5.2.2. Swine/ Porcine
  - 5.2.3. Poultry
  - 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast - by Route of Administration
  - 5.3.1. Oral
  - 5.3.2. Parenteral
  - 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - by Distributional Channel
  - 5.4.1. Veterinary Hospitals
  - 5.4.2. Veterinary Clinics
  - 5.4.3. Others
- 5.5. Market Analysis, Insights and Forecast - by Region
  - 5.5.1.
6. Competitive Analysis
- 6.1. Market Share Analysis 2025
- - 6.2. Company Profiles
  - - 6.2.1 Boehringer Ingelheim International GmbH (Germany)
      6.2.1.1. Overview
      6.2.1.2. Products
      6.2.1.3. SWOT Analysis
      6.2.1.4. Recent Developments
      6.2.1.5. Financials (Based on Availability)
    - 6.2.2 Virbac (France)
      6.2.2.1. Overview
      6.2.2.2. Products
      6.2.2.3. SWOT Analysis
      6.2.2.4. Recent Developments
      6.2.2.5. Financials (Based on Availability)
    - 6.2.3 Merck Animal Health (Merck & Co. Inc.) (U.S.)
      6.2.3.1. Overview
      6.2.3.2. Products
      6.2.3.3. SWOT Analysis
      6.2.3.4. Recent Developments
      6.2.3.5. Financials (Based on Availability)
    - 6.2.4 Zoetis Services LLC (U.S.)
      6.2.4.1. Overview
      6.2.4.2. Products
      6.2.4.3. SWOT Analysis
      6.2.4.4. Recent Developments
      6.2.4.5. Financials (Based on Availability)
    - 6.2.5 Ceva (France)
      6.2.5.1. Overview
      6.2.5.2. Products
      6.2.5.3. SWOT Analysis
      6.2.5.4. Recent Developments
      6.2.5.5. Financials (Based on Availability)
    - 6.2.6 Elanco (U.S.)
      6.2.6.1. Overview
      6.2.6.2. Products
      6.2.6.3. SWOT Analysis
      6.2.6.4. Recent Developments
      6.2.6.5. Financials (Based on Availability)
    - 6.2.7 Neogen Corporation (U.S.)
      6.2.7.1. Overview
      6.2.7.2. Products
      6.2.7.3. SWOT Analysis
      6.2.7.4. Recent Developments
      6.2.7.5. Financials (Based on Availability)

List of Figures

Figure 1: U.S. Livestock Vaccines Market Revenue Breakdown (USD Billion, %) by Product 2025 & 2033
Figure 2: U.S. Livestock Vaccines Market Share (%) by Company 2025

List of Tables

Table 1: U.S. Livestock Vaccines Market Revenue USD Billion Forecast, by Type 2020 & 2033
Table 2: U.S. Livestock Vaccines Market Volume No.of doses Forecast, by Type 2020 & 2033
Table 3: U.S. Livestock Vaccines Market Revenue USD Billion Forecast, by Animal Type 2020 & 2033
Table 4: U.S. Livestock Vaccines Market Volume No.of doses Forecast, by Animal Type 2020 & 2033
Table 5: U.S. Livestock Vaccines Market Revenue USD Billion Forecast, by Route of Administration 2020 & 2033
Table 6: U.S. Livestock Vaccines Market Volume No.of doses Forecast, by Route of Administration 2020 & 2033
Table 7: U.S. Livestock Vaccines Market Revenue USD Billion Forecast, by Distributional Channel 2020 & 2033
Table 8: U.S. Livestock Vaccines Market Volume No.of doses Forecast, by Distributional Channel 2020 & 2033
Table 9: U.S. Livestock Vaccines Market Revenue USD Billion Forecast, by Region 2020 & 2033
Table 10: U.S. Livestock Vaccines Market Volume No.of doses Forecast, by Region 2020 & 2033
Table 11: U.S. Livestock Vaccines Market Revenue USD Billion Forecast, by Type 2020 & 2033
Table 12: U.S. Livestock Vaccines Market Volume No.of doses Forecast, by Type 2020 & 2033
Table 13: U.S. Livestock Vaccines Market Revenue USD Billion Forecast, by Animal Type 2020 & 2033
Table 14: U.S. Livestock Vaccines Market Volume No.of doses Forecast, by Animal Type 2020 & 2033
Table 15: U.S. Livestock Vaccines Market Revenue USD Billion Forecast, by Route of Administration 2020 & 2033
Table 16: U.S. Livestock Vaccines Market Volume No.of doses Forecast, by Route of Administration 2020 & 2033
Table 17: U.S. Livestock Vaccines Market Revenue USD Billion Forecast, by Distributional Channel 2020 & 2033
Table 18: U.S. Livestock Vaccines Market Volume No.of doses Forecast, by Distributional Channel 2020 & 2033
Table 19: U.S. Livestock Vaccines Market Revenue USD Billion Forecast, by Country 2020 & 2033
Table 20: U.S. Livestock Vaccines Market Volume No.of doses Forecast, by Country 2020 & 2033

Methodology

Step 1 - Identification of Relevant Samples Size from Population Database

Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

Note*: In applicable scenarios

Step 3 - Data Sources

Primary Research

Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders

Secondary Research

Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations

Step 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.

Frequently Asked Questions

1. What is the projected Compound Annual Growth Rate (CAGR) of the U.S. Livestock Vaccines Market?

The projected CAGR is approximately 6.0%.

2. Which companies are prominent players in the U.S. Livestock Vaccines Market?

Key companies in the market include Boehringer Ingelheim International GmbH (Germany), Virbac (France), Merck Animal Health (Merck & Co., Inc.) (U.S.), Zoetis Services LLC (U.S.), Ceva (France), Elanco (U.S.), Neogen Corporation (U.S.).

3. What are the main segments of the U.S. Livestock Vaccines Market?

The market segments include Type, Animal Type, Route of Administration, Distributional Channel.

4. Can you provide details about the market size?

The market size is estimated to be USD 2.36 USD Billion as of 2022.

5. What are some drivers contributing to market growth?

Growing Awareness Regarding Contraceptive Drugs Leads to Product Demand.

6. What are the notable trends driving market growth?

Increasing Number of Hospitals and ASCs Identified as Significant Market Trend.

7. Are there any restraints impacting market growth?

Growing Concerns Over Vaccine Failure Could Hinder the Market Growth.

8. Can you provide examples of recent developments in the market?

July 2023- The College of Veterinary Medicine of the Kansas State University announced the inauguration of a Center on Vaccine Evaluation and Alternatives for Antimicrobials (CVEAA). The center will support research and development of new and innovative livestock and animal vaccines.

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 2850, USD 3850, and USD 4850 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in USD Billion and volume, measured in No.of doses.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "U.S. Livestock Vaccines Market," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the U.S. Livestock Vaccines Market report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

14. How can I stay updated on further developments or reports in the U.S. Livestock Vaccines Market?

To stay informed about further developments, trends, and reports in the U.S. Livestock Vaccines Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

Get Free Sample

Pre Order Enquiry Request discount

Pricing

Related Reports

U.S. Vaccines Market Decade Long Trends, Analysis and Forecast 2025-2033

U.S. Veterinary Vaccines Market Report Probes the USD Billion Size, Share, Growth Report and Future Analysis by 2033

Livestock Vaccines Market Charting Growth Trajectories: Analysis and Forecasts 2025-2033

Veterinary/Animal Vaccines Market Charting Growth Trajectories: Analysis and Forecasts 2025-2033

Livestock Vaccine Analysis Report 2025: Market to Grow by a CAGR of 5 to 2033, Driven by Government Incentives, Popularity of Virtual Assistants, and Strategic Partnerships

Tailored for you

In-depth Analysis Tailored to Specified Regions or Segments
Company Profiles Customized to User Preferences
Comprehensive Insights Focused on Specific Segments or Regions
Customized Evaluation of Competitive Landscape to Meet Your Needs
Tailored Customization to Address Other Specific Requirements

Ask for customization

The response was good, and I got what I was looking for as far as the report. Thank you for that.

Erik Perison

US TPS Business Development Manager at Thermon

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report